Key questions on the long term renal effects of lithium: a review of pertinent data
- PMID: 37971552
- PMCID: PMC10654310
- DOI: 10.1186/s40345-023-00316-5
Key questions on the long term renal effects of lithium: a review of pertinent data
Abstract
For over half a century, it has been widely known that lithium is the most efficacious maintenance treatment for bipolar disorder. Despite thorough research on the long-term effects of lithium on renal function, a number of important questions relevant to clinical practice remain. The risk of polyuria, reflecting renal tubular dysfunction, is seen in a substantial proportion of patients treated with long term lithium therapy. The duration of lithium may be the most important risk factor for lithium-induced polyuria. Most, but not all, studies find that lithium is associated with higher rates of chronic kidney disease compared to either age matched controls or patients treated with other mood stabilizers. Age, duration of lithium therapy and medical disorders such as hypertension and diabetes mellitus are risk factors for chronic kidney disease in lithium-treated patients. The relationship between polyuria and chronic kidney disease is inconsistent but poorly studied. Although not all studies agree, it is likely that lithium may increase the risk for end stage renal disease but in a very small proportion of treated patients. Patients whose renal function is relatively preserved will show either no progression or improvement of renal function after lithium discontinuation. In contrast, patients with more renal damage frequently show continued deterioration of renal function even after lithium discontinuation. Optimal management of lithium treatment requires obtaining a baseline measure of renal function (typically estimated glomerular filtration rate [eGFR]) and regular monitoring of eGFR during treatment. Should the eGFR fall rapidly or below 60 ml/minute, patients should consider a consultation with a nephrologist. A decision as to whether lithium should be discontinued due to progressive renal insufficiency should be made using a risk/benefit analysis that takes into account other potential etiologies of renal dysfunction, current renal function, and the efficacy of lithium in that individual patient.
Keywords: Bipolar disorder; Kidney function; Maintenance treatment; lithium.
© 2023. The Author(s).
Conflict of interest statement
MG has no conflicts of interest to declare with respect to the research, authorship and/or publication of this article. MB has received research grants by the Deutsche Forschungsgemeinschaft (DFG), Bundesministerium für Bildung und Forschung (BMBF), Gemeinsamer Bundesausschuss- Innovationsausschuss, European Commission, Sächsisches Staatsministerium für Wissenschaft, Kultur und Tourismus (SMWK); SAB, and served as consultant, advisor or speaker for Biogen, COMPASS Pathfinder, GH Research, F. Hoffmann-La Roche, Janssen, Janssen-Cilag, Livanova Deutschland GmbH, Novartis, Sunovion, Takeda, neuraxpharm, Shire International GmbH, Aristo, Servier Deutschland GmbH and Hexal AG.
Similar articles
-
Renal function after withdrawal of lithium.Bipolar Disord. 2022 Sep;24(6):667-670. doi: 10.1111/bdi.13178. Epub 2022 Feb 1. Bipolar Disord. 2022. PMID: 35075735
-
[Chronic renal complications induced by lithium].Encephale. 2009 Dec;35(6):605-10. doi: 10.1016/j.encep.2008.12.007. Encephale. 2009. PMID: 20004292 Review. French.
-
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study.BMC Med. 2013 Feb 11;11:33. doi: 10.1186/1741-7015-11-33. BMC Med. 2013. PMID: 23399351 Free PMC article.
-
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study.BMC Med. 2015 Jan 21;13:12. doi: 10.1186/s12916-014-0249-4. BMC Med. 2015. PMID: 25604586 Free PMC article.
-
Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.CNS Drugs. 2009;23(5):397-418. doi: 10.2165/00023210-200923050-00004. CNS Drugs. 2009. PMID: 19453201 Review.
Cited by
-
Lithium in Drinking Water and its Potential Impact on Mental Health: A Review.Curr Med Chem. 2025;32(19):3735-3747. doi: 10.2174/0109298673315171240702103413. Curr Med Chem. 2025. PMID: 38988157 Review.
-
Prescribing lithium for the management of persons suffering from bipolar disorders: expert consensus based on a Delphi study.Int J Bipolar Disord. 2025 Jun 7;13(1):21. doi: 10.1186/s40345-025-00387-6. Int J Bipolar Disord. 2025. PMID: 40481905 Free PMC article.
-
Lithium in the time of COVID: forever vigilant.Int J Bipolar Disord. 2024 Aug 7;12(1):29. doi: 10.1186/s40345-024-00351-w. Int J Bipolar Disord. 2024. PMID: 39112765 Free PMC article.
-
Lithium: current state of the art and future directions.Int J Bipolar Disord. 2024 Nov 28;12(1):40. doi: 10.1186/s40345-024-00362-7. Int J Bipolar Disord. 2024. PMID: 39609318 Free PMC article. Review.
-
Effectiveness of ultra-long-term lithium treatment: relevant factors and case series.Int J Bipolar Disord. 2024 Mar 15;12(1):7. doi: 10.1186/s40345-024-00328-9. Int J Bipolar Disord. 2024. PMID: 38489135 Free PMC article. Review.
References
-
- Aiff H, Attman P, Aurell M, Bendz H, SchÓ§n S, Svedlund J. The impact of modern treatment principles may have eliminated lithium-induced Renal Failure. J Psychopharmacol. 2014B; 151–4. - PubMed
-
- Aiff H, Attman P, Aurell M, Bendz H, SchÓ§n S, Svedlund J. End-stage renal Disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol. 2014A;24:540–4. - PubMed
-
- Bassilios N, Martel P, Godard V, Froissart M, Grϋnfeld J. Stengel B on behalf of the Réseau Néphropar. Monitoring of glomerular filtration rate in lithium-treated outpatients-an ambulatory laboratory database surveillance. Nephrol Dial Transplant. 2008;23:562–5. doi: 10.1093/ndt/gfm567. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous